Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.462 USD | +1.07% | +2.17% | -68.36% |
06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.36% | 1.46Cr | |
-1.26% | 8.95TCr | |
+2.76% | 4.07TCr | |
-8.93% | 3.3TCr | |
+55.32% | 2.47TCr | |
-16.10% | 1.51TCr | |
-8.73% | 1.28TCr | |
-12.11% | 1.18TCr | |
-43.61% | 1.16TCr | |
+7.79% | 890.22Cr |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- RedHill Biopharma : HC Wainwright Starts Redhill Biopharma at Buy With $23 Price Target